Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut
Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut.
Drug Metab Dispos. 2023 Jun;51(6):647-656. doi: 10.1124/dmd.122.001006. Epub 2023 Mar 27.
Human absorption, distribution, metabolism, and excretion (hADME) studies represent one of the most important clinical studies in terms of obtaining a comprehensive and quantitative overview of the total disposition of a drug. This article will provide background on the origins of hADME studies as well as provide an overview of technological innovations that have impacted how hADME studies are carried out and analyzed. An overview of the current state of the art for hADME studies will be provided, the impacts of advances in technology and instrumentation on the timing of and approaches to hADME studies will be discussed, and a summary of the parameters and information obtained from these studies will be offered. Additionally, aspects of the ongoing debate over the importance of animal absorption, distribution, metabolism, and excretion studies versus a "human-first, human-only strategy" will be presented. Along with the information above, this manuscript will highlight how, for over 50 years, has served as an important outlet for the reporting of hADME studies. SIGNIFICANCE STATEMENT: Human absorption, distribution, metabolism, and excretion (hADME) studies have and will continue to be important to the understanding and development of drugs. This manuscript provides a historical perspective on the origins of hADME studies as well as advancements resulting in the current-state-of the art practice for these studies.
人体吸收、分布、代谢和排泄(hADME)研究是获得药物总体处置情况全面和定量概述的最重要的临床研究之一。本文将提供 hADME 研究起源的背景信息,并概述影响 hADME 研究进行和分析的技术创新。将提供 hADME 研究现状概述,讨论技术和仪器设备的进步对 hADME 研究时间和方法的影响,并提供从这些研究中获得的参数和信息的摘要。此外,还将介绍正在进行的关于动物吸收、分布、代谢和排泄研究与“以人为主、仅以人为研究对象”策略重要性的争论的各个方面。除了上述信息外,本文还将重点介绍 50 多年来,一直是 hADME 研究报告的重要渠道。
人体吸收、分布、代谢和排泄(hADME)研究对于理解和开发药物一直很重要,并且将继续如此。本文提供了 hADME 研究起源的历史视角,以及导致这些研究当前实践的最新技术进步。